|
|
|
Volumn 27, Issue 2, 2002, Pages 79-93
|
|
The multifaceted potential of glucagon-like peptide-1 as a therapeutic agent.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
GLUCAGON;
GLUCAGON LIKE PEPTIDE 1;
GLUCAGON LIKE PEPTIDE RECEPTOR;
GLUCAGON RECEPTOR;
GLUCAGON-LIKE PEPTIDE RECEPTOR;
INSULIN;
PEPTIDE FRAGMENT;
PROTEIN PRECURSOR;
ANIMAL;
BIOSYNTHESIS;
CLINICAL TRIAL;
DRUG ADMINISTRATION ROUTE;
DRUG EFFECT;
EXPERIMENTAL DIABETES MELLITUS;
GENE EXPRESSION REGULATION;
GLUCOSE BLOOD LEVEL;
HUMAN;
INSULIN RESISTANCE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PANCREAS ISLET;
PHYSIOLOGY;
PSYCHOPHYSIOLOGY;
RAT;
REVIEW;
SECRETION;
SIGNAL TRANSDUCTION;
SMALL INTESTINE;
STOMACH EMPTYING;
ANIMALS;
BLOOD GLUCOSE;
CLINICAL TRIALS;
DIABETES MELLITUS, EXPERIMENTAL;
DIABETES MELLITUS, TYPE 2;
DRUG ADMINISTRATION ROUTES;
GASTRIC EMPTYING;
GENE EXPRESSION REGULATION;
GLUCAGON;
GLUCAGON-LIKE PEPTIDE 1;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
INSULIN RESISTANCE;
INTESTINE, SMALL;
ISLETS OF LANGERHANS;
PEPTIDE FRAGMENTS;
PROTEIN PRECURSORS;
RATS;
RECEPTORS, GLUCAGON;
SATIETY RESPONSE;
SIGNAL TRANSDUCTION;
|
|
EID: 0036617088
PISSN: 03911977
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (10)
|
|
References (183)
|
